Thermostable variants of T7 RNA polymerase
A bacteriophage RNA polymerase variant is provided. In some embodiments, the variant may have increased thermostability relative to the corresponding wild type bacteriophage RNA polymerase and/or wild type T7 RNA polymerase. Compositions, kits and methods that employ the variant are also provided.
1. An RNA polymerase, wherein the RNA polymerase:
(a) has at least 90% sequence identity to SEQ ID NO:1; and
(b) comprises at least one amino acid substitution corresponding to a position selected from the group consisting of: 109, 205, 534, 567, and 618 of SEQ ID NO:1.
2. An RNA polymerase of claim 1 , wherein the RNA polymerase comprises at least two substitutions at positions corresponding to positions selected from the group consisting of: 109, 205, 388, 534, 567, and 618 of SEQ ID NO:1.
3. An RNA polymerase of claim 1 , wherein the RNA polymerase comprises substitutions at positions corresponding to positions 109, 205, 534, 567, and 618 of SEQ ID NO:1.
4. An RNA polymerase of claim 1 , wherein the substitution corresponding to position 109 of SEQ ID NO:1 is I109L, the substitution corresponding to position 205 of SEQ ID NO:1 is H205S, the substitution corresponding to position 534 of SEQ ID NO:1 is L534V, the substitution corresponding to position 567 of SEQ ID NO:1 is V567P and the substitution corresponding to position 618 of SEQ ID NO:1 is G618Q.
5. An RNA polymerase of claim 1 , further comprising at least one additional amino acid substitution at a position corresponding to a position selected from the group consisting of: 75, 83, 108, 206, 227, 281, 297, 312, 323, 327, 333, 340, 354, 362, 375, 388,428, 446, 454, 461, 495, 510, 584, 591, 642, 711, 724, 740, 788, 832, 834, 835, 843, 847, 849, 856, 863, 866 and 877 of SEQ ID NO:1.
6. An RNA polymerase of claim 1 , comprising at least 10 additional substitutions at positions corresponding to a position selected from the group consisting of: 75, 83, 108, 206, 227, 281, 297, 312, 323, 327, 333, 340, 354, 362, 375, 788, 428, 446, 454, 461, 495, 510, 584, 591, 642, 711, 724, 740, 788, 832, 834, 835, 843, 847, 849, 856, 863, 866 and 877 of SEQ ID NO:1.
7. An RNA polymerase of claim 1 , comprising at least one additional amino acid substitution selected from the group consisting of: T75Q, A83K, E108L, K206P, V227I, I281P, V297I, Y312D, A323I, A327P, K333P, V340E, A354Q, M362P, T375K, T375N, D388E, A428P, L446F, K454P, K461R, S495N, C510Q, A584K, D591E, K642R, K711R, A724P, K740R, G788A, M832F, D834E, T835L, A843Q, D847E, F849V, S856T, A863P, A866K and E877R of SEQ ID NO:1.
8. An RNA polymerase of claim 1 , comprising at least ten additional substitutions selected from the group consisting of: T75Q, A83K, E108L, K206P, V227I, I281P, V297I, Y312D, A323I, A327P, K333P, V340E, A354Q, M362P, T375K, T375N, D388E, A428P, L446F, K454P, K461R, S495N, C510Q, A584K, D591E, K642R, K711R, A724P, K740R, G788A, M832F, D834E, T835L, A843Q, D847E, F849V, S856T, A863P, A866K and E877R of SEQ ID NO:1.
9. An RNA polymerase of claim 1 , wherein, as a result of the at least one amino acid substitution, the RNA polymerase has increased activity at temperatures above 42° C., 45° C., 50° C. or 55° C. relative to the T7 RNA polymerase of SEQ ID NO:1.
10. An RNA polymerase of claim 1 , wherein the polymerase has at least 95% sequence identity to any of SEQ ID NOs: 52-59, 69 and 70.
11. A fusion protein comprising:
the RNA polymerase of claim 1 ; and
a DNA binding domain.
12. A composition comprising:
the RNA polymerase of claim 1 ; and
a buffering agent.
13. A composition of claim 12 , further comprising ribonucleoside triphosphates and/or a modified nucleotide.
14. A composition of claim 12 , further comprising glycerol, salt, EDTA, and/or detergent.
15. A composition of claim 12 , further comprising a template DNA molecule comprising: a bacteriophage RNA polymerase promoter, operably linked to a target nucleotide sequence to be transcribed.
16. A composition of claim 12 , further comprising a temperature sensitive inhibitor of the RNA polymerase.